Kempen Capital Management

Kempen Capital Management

Kempen Capital Management

Overview
Date Founded

1991

Headquarters

Beethovenstraat 300 PO Box 75666 Amsterdam, 1077 WZ, Netherlands

Type of Company

Private

Industries

Investment Services & Portfolio Management

Company Description

Kempen is an asset manager with a long-term investment approach. They engage with their investees on strategic, financial and ESG topics to implement their vision. Their long-term investment worldview combined with a thorough analysis and experienced ESG team allows them to leverage their fully integrated active ownership approach as a means to consistently encourage positive change. The firm is able to contribute to the development of principles and standards of corporate responsibility at the companies that they invest in through this process of integrating material governance and sustainability factors in their investment decisions and constructive engagement. Kempen's selective strategies include private markets, real estate, infrastructure, small-caps, sustainable value creation, high dividend equities, hedge fund solutions, euro credits and government bonds.

Contact Data
Trying to get in touch with decision makers at Kempen Capital Management? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Executive Director Private Client Solutions & Private Markets

Chief Investment Officer

Chief Operating Officer

Head of Credit Team

Head of Sustainable Value Creation

Head of Research

Senior Portfolio Manager & Co-Head Hedge Fund Solutions

Head of Small Caps

Head of Dividend Team

Board of Directors

Former Chief Executive Officer at Kempen Capital Management

Paths to Kempen Capital Management
Potential Connections via
Relationship Science
You
Kempen Capital Management
Recent Transactions
Details Hidden

Kempen Capital Management, Van Lanschot Kempen NV purchase Mn Services Vermogensbeheer BV (UK) from Mn Services NV

Investments
Details Hidden

Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Kempen Capital Management. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Kempen Capital Management's profile does not indicate a business or promotional relationship of any kind between RelSci and Kempen Capital Management.